• 1. Department of Liver Surgery, West China Hospital of Sichuan University, Chengdu 610041, P. R. China;
  • 2. Department of General Surgery, People’s Hospital of Tibet Autonomous Region, Lhasa 850000, P. R. China;
WEI Yonggang, Email: yourwyg@163.com
Export PDF Favorites Scan Get Citation

Objective To investigate the effect of intermittent Pringle (IP) and continuous hemi-hepatic vascular inflow occlusion (CHVIO) on the prognosis of patients with hepatocellular carcinoma (HCC) complicated with cirrhosis in laparoscopic liver resection (LLR).Methods Retrospective analysis of consecutive 107 LLR patients with HCC complicated with liver cirrhosis at West China Hospital of Sichuan University between January 2015 and December 2017 was performed. Patients were divided into an IP group and a CHVIO group according to the method of hepatic vascular occlusion, intraoperative and postoperative outcome indicators and short-term prognosis were compared between the two groups.Results Patients in the IP group had shorter operative time [(237+90) min vs (285+118) min, P=0.041] and less blood loss [(279+24) mL vs (396+35) mL, P=0.012], without a significant increase in postoperative liver function [including ALT, AST, TBIL, and ALB], postoperative complications, induced flow, 1-year disease-free survival, and1-year survival (P>0.05).Conclusions IP can reduce the operative time and blood loss in patients with HCC complicated with cirrhosis in LLR, and will not lead to deterioration of liver function, it is a recommended hepatic inflowocclusion method.

Citation: YE Junshan, WEI Yonggang, LAN Xiang, LIU Fei, LI Bo, ZHANG Hua, XU Hongwei, HE Zhongping, ZHAO Rongce, WANG Linyuan. Safety comparison of laparoscopic hepatic blood flow occlusion for hepatectomy in HCC patients with cirrhosis. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2019, 26(2): 141-147. doi: 10.7507/1007-9424.201811084 Copy

  • Previous Article

    腹腔镜肝脏切除术的肝门血流阻断及断肝技巧
  • Next Article

    Result of surgical treatment of hypertrophic obstructive cardiomyopathy with coronary heart disease